ECM
TXG icon

Evergreen Capital Management’s 10x Genomics TXG Stock Holding History

Evergreen Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Sell
13,766
-991
-7% -$19.8K 0.01% 1140
2025
Q4 		$241K Buy
+14,757
New +$223K 0.01% 1190
2025
Q2 		– Sell
-10,850
Closed -$94.7K – 1255
2025
Q1 		$94.7K Buy
+10,850
New +$137K ﹤0.01% 1068
2021
Q2 		– Sell
-1,206
Closed -$218K – 555
2021
Q1 		$218K Buy
+1,206
New +$208K 0.01% 463

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Evergreen Capital Management's TXG Position: Q1 2026 in Review

Evergreen Capital Management reduced its 10x Genomics (TXG) stake by 6.7% in Q1 2026, selling an estimated $19.8K and leaving 13,766 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #1140.

Evergreen Capital Management first reported a position in TXG in Q1 2021 and has held it in 4 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Evergreen Capital Management held 13,766 shares of 10x Genomics worth $292K as of Q1 2026.
  • Evergreen Capital Management sold 991 10x Genomics shares in Q1 2026, an estimated $19.8K.
  • 10x Genomics made up 0.01% of Evergreen Capital Management's portfolio in Q1 2026, its #1140 holding.
  • Evergreen Capital Management first reported a position in 10x Genomics in Q1 2021 and has held it in 4 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.